A detailed history of Legacy Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Legacy Advisors, LLC holds 8,745 shares of NVO stock, worth $775,768. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,745
Previous 7,906 10.61%
Holding current value
$775,768
Previous $1.13 Million 7.71%
% of portfolio
0.11%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $99,899 - $122,007
839 Added 10.61%
8,745 $1.04 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $215,969 - $258,561
1,760 Added 28.64%
7,906 $1.13 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $627,568 - $835,364
6,146 New
6,146 $789,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Legacy Advisors, LLC Portfolio

Follow Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.